Roberts Glore & CO Inc Baxter International Inc Transaction History

Roberts Glore & CO Inc

  • $328 Million
  • Q2 2024

A detailed history of Roberts Glore & CO Inc transactions in Baxter International Inc stock. As of the latest transaction made, Roberts Glore & CO Inc holds 14,089 shares of BAX stock, worth $549,048. This represents 0.14% of its overall portfolio holdings.

Number of Shares
14,089
Previous 13,804 2.06%
Holding current value
$549,048
Previous $589,000 20.03%
% of portfolio
0.14%
Previous 0.18%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$32.87 - $43.55 $9,367 - $12,411
285 Added 2.06%
14,089 $471,000
Q1 2024

May 09, 2024
BUY
$37.88 - $43.77 $7,576 - $8,754
200 Added 1.47%
13,804 $589,000
Q4 2023

Feb 12, 2024
BUY
$31.71 - $38.95 $3,963 - $4,868
125 Added 0.93%
13,604 $525,000
Q3 2023

Nov 13, 2023
BUY
$37.32 - $49.29 $163,275 - $215,643
4,375 Added 48.06%
13,479 $508,000
Q2 2023

Aug 14, 2023
BUY
$39.98 - $47.68 $199 - $238
5 Added 0.05%
9,104 $414,000
Q1 2023

May 08, 2023
BUY
$37.58 - $52.57 $107,854 - $150,875
2,870 Added 46.07%
9,099 $369,000
Q4 2022

Feb 13, 2023
SELL
$49.7 - $57.71 $2,186 - $2,539
-44 Reduced 0.7%
6,229 $317,000
Q2 2022

Aug 11, 2022
SELL
$63.83 - $80.0 $1,595 - $2,000
-25 Reduced 0.4%
6,273 $403,000
Q1 2022

May 02, 2022
SELL
$76.85 - $89.45 $1,921 - $2,236
-25 Reduced 0.4%
6,298 $488,000
Q4 2021

Feb 11, 2022
SELL
$74.57 - $87.19 $19,761 - $23,105
-265 Reduced 4.02%
6,323 $543,000
Q3 2021

Nov 12, 2021
SELL
$73.77 - $83.61 $12,172 - $13,795
-165 Reduced 2.44%
6,588 $530,000
Q2 2021

Aug 10, 2021
SELL
$80.5 - $88.01 $402 - $440
-5 Reduced 0.07%
6,753 $544,000
Q1 2021

May 06, 2021
SELL
$76.38 - $86.03 $162,536 - $183,071
-2,128 Reduced 23.95%
6,758 $570,000
Q2 2020

Aug 13, 2020
SELL
$78.66 - $94.14 $1,573 - $1,882
-20 Reduced 0.22%
8,886 $765,000
Q1 2020

May 11, 2020
SELL
$71.57 - $93.3 $104,492 - $136,218
-1,460 Reduced 14.08%
8,906 $723,000
Q4 2019

Feb 13, 2020
BUY
$76.7 - $88.45 $424,151 - $489,128
5,530 Added 114.35%
10,366 $866,000
Q3 2019

Nov 08, 2019
SELL
$81.4 - $89.78 $2,849 - $3,142
-35 Reduced 0.72%
4,836 $423,000
Q2 2019

Aug 09, 2019
SELL
$73.44 - $82.41 $19,461 - $21,838
-265 Reduced 5.16%
4,871 $399,000
Q4 2018

Feb 08, 2019
SELL
$61.45 - $77.8 $26,116 - $33,065
-425 Reduced 7.64%
5,136 $338,000
Q3 2018

Nov 09, 2018
SELL
$70.71 - $77.75 $4,596 - $5,053
-65 Reduced 1.16%
5,561 $429,000
Q1 2018

May 08, 2018
SELL
$62.56 - $72.26 $7,194 - $8,309
-115 Reduced 2.0%
5,626 $366,000
Q4 2017

Feb 09, 2018
SELL
$61.45 - $66.05 $7,681 - $8,256
-125 Reduced 2.13%
5,741 $371,000
Q3 2017

Nov 08, 2017
SELL
$59.5 - $64.61 $17,850 - $19,383
-300 Reduced 4.87%
5,866 $368,000
Q2 2017

Aug 15, 2017
BUY
N/A
6,166
6,166 $373,000

Others Institutions Holding BAX

# of Institutions
981
Shares Held
446M
Call Options Held
2.22M
Put Options Held
3.04M
View Full List

About BAXTER INTERNATIONAL INC

BAX Quotes by TradingView
  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $19.6B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Roberts Glore & CO Inc Portfolio

Follow Roberts Glore & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roberts Glore & CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Roberts Glore & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email